Vascular and Endovascular Surgery S (EIN 272651673) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1989

Legal Domicile

Tax Period

2023-01-01 to 2023-12-31

Vascular and Endovascular Surgery S, founded in 1989, is a small nonprofit in the Medical Research sector that reported $807K in total revenue in fiscal year 2023. Revenue grew 18% year-over-year, indicating healthy expansion. The organization ran a surplus of $249K, a strong 31% operating margin.

Mission

To improve the quality and safety of vascular and endovascular surgical procedures and general vascular care through education, scholarship, advocacy and leadership.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $125,825

Program Service Revenue $667,509

Investment Income $13,471

Other Revenue $240

TOTAL REVENUE $807,045

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $411,036

Other Expenses $558,391

TOTAL EXPENSES $558,391

Year-over-Year Comparison

	2023	2022	Change
Revenue	$807,045	$686,453	+0.2%
Expenses	$558,391	$719,413	-0.2%
Net Income	$248,654	$-32,960	-8.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Kristine Orion	Councilor	1.00	Director	$0	$0	$0
Karan Garg	Coucilor	1.00	Director	$0	$0	$0
Jean Marie Ruddy	Councilor	1.00	Director	$0	$0	$0
Jordan Stern	Councilor	1.00	Director	$0	$0	$0
Ravi Rajani	Recorder	1.00	Director	$0	$0	$0
Misty Humphries	President-Elect	1.00	Officer Director	$0	$0	$0
Mark Conrad	President	1.00	Officer Director	$0	$0	$0
Todd Berland	Treasurer	1.00	Officer Director	$0	$0	$0
Dawn Coleman	Secretary	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$807,045	$558,391	$1,371,090	$248,654
2022	$686,453	$719,413	$1,088,567	$-32,960
2021	$594,853	$428,768	$1,121,888	$166,085
2020	$386,530	$495,345	$966,041	$-108,815
2019	$660,897	$443,611	$1,079,975	$217,286
2018	$575,661	$485,143	$847,278	$90,518

Vascular and Endovascular Surgery S